Cargando…
Value Added by the Prevnar 13 Childhood Immunization Program in Alberta, Canada (2010–2015)
BACKGROUND: Streptococcus pneumoniae is a pathogen causing acute respiratory infections, as well as meningitis and bacteremia. The province of Alberta, Canada, began vaccinating infants against seven S. pneumoniae serotypes in 2002 using Prevnar 7 (PCV7). However, a 13-valent conjugate vaccine (PCV1...
Autores principales: | Waye, Arianna, Chuck, Anderson W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883219/ https://www.ncbi.nlm.nih.gov/pubmed/27747577 http://dx.doi.org/10.1007/s40801-015-0037-2 |
Ejemplares similares
-
Prevnar 7 Childhood Immunization Program and Serotype Replacement: Changes in Pneumococcal Incidence and Resulting Impact on Health Care Costs in Alberta (2003–2008)
por: Waye, Arianna, et al.
Publicado: (2015) -
Mathematical Modelling Long-Term Effects of Replacing Prevnar7 with Prevnar13 on Invasive Pneumococcal Diseases in England and Wales
por: Choi, Yoon Hong, et al.
Publicado: (2012) -
Epidemiology of pertussis in Alberta, Canada 2004–2015
por: Liu, Xianfang C., et al.
Publicado: (2017) -
From “Glivec(®)” to “Prevnar 13(®)”: How strong is the Indian drug patenting system?
por: Raj, Gerard Marshall
Publicado: (2018) -
1432. County-Wide Pediatric IPD Experience Following Prevnar 13 Implementation
por: Nieves, Delma, et al.
Publicado: (2018)